Clinical trials
Active, not recruiting Endometrial Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| National Cancer Institute (NCI) | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Eisai Inc. | 1 |
| Gilead Sciences | 1 |
| Karyopharm Therapeutics Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 19 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colorectal Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.